Can GLP-1 Drugs Cause Hair Loss? 2026 Evidence

Medically reviewed by the HyaluFlow Health Editorial Team | Published: July 31, 2026 | Last Updated: July 31, 2026

GLP-1 drugs have changed weight management. Medications such as semaglutide and tirzepatide can lead to substantial weight loss.

But some users notice another change: increased hair shedding.

More hair may appear in the shower, on a pillow, or on a brush. This can be alarming.

So, can GLP-1 drugs cause hair loss?

Current evidence says there is an association. However, rapid weight loss may be a major reason. Reduced food intake and nutritional changes may also play a role.

What Does the Research Say About GLP-1 Hair Loss?

The evidence has become stronger in 2026.

A systematic review and meta-analysis published in Diabetes Research and Clinical Practice included nine interventional studies with 4,114 GLP-1 users. Hair loss was significantly more common among GLP-1 users than placebo users. The pooled risk ratio was 3.25. [1]

Another 2026 systematic review examined 24 studies. It found that semaglutide and tirzepatide had the strongest hair-loss signals among the GLP-1 drugs studied. Telogen effluvium was one of the main reported patterns. [2]

The FDA prescribing information for Wegovy also lists hair loss as an adverse reaction. In adult weight-management trials, hair loss occurred in 3.3% of people receiving Wegovy 2.4 mg compared with 1% receiving placebo. The prescribing information notes that these reactions were associated with weight reduction. [3]

Still, there is an important limitation.

These findings show an association. They do not prove that GLP-1 drugs directly damage hair follicles.

Why Might GLP-1 Drugs Trigger Hair Shedding?

Rapid weight loss

Rapid weight loss may be the biggest factor.

A major change in body weight can stress the body. This can push more hair follicles into a resting phase.

The hairs may then shed later.

This process is called telogen effluvium.

The American Academy of Dermatology says dermatologists believe much of the hair thinning seen with GLP-1 drugs may be related to sudden weight loss. [4]

Reduced food intake

GLP-1 drugs reduce appetite. That helps create a calorie deficit.

But eating much less can also make it harder to get enough protein and other nutrients.

Protein, iron, zinc, and several vitamins support normal hair growth.

This does not mean GLP-1 users will automatically develop nutrient deficiencies. It means adequate nutrition becomes especially important when food intake falls sharply.

Could the medication itself affect hair?

Researchers have not ruled this out.

A direct effect on hair growth remains possible. But current evidence cannot clearly separate a medication effect from the effects of rapid weight loss and reduced food intake. [2,5]

What Is Telogen Effluvium?

Telogen effluvium is a common form of temporary hair shedding.

Hair follicles normally move through different growth phases. A major physical stressor can disrupt this cycle.

More hairs then enter the resting phase.

Those hairs can shed weeks or months later.

This delay can make GLP-1-related shedding confusing. The hair loss may appear after the major weight loss has already happened.

Recent reviews identify telogen effluvium as one of the main hair-loss patterns reported with GLP-1 therapy. [2,5]

Do Semaglutide and Tirzepatide Cause Hair Loss?

Both drugs have been linked with hair loss.

Recent evidence suggests semaglutide and tirzepatide have stronger hair-loss signals than some other GLP-1 drugs. Tirzepatide was frequently associated with telogen effluvium in the 2026 systematic review. [2]

One possible explanation is the amount of weight lost.

Tirzepatide can produce substantial weight loss. A larger change in body weight may increase the risk of temporary shedding.

However, this is not proof that tirzepatide directly damages hair.

Is GLP-1 Hair Loss Permanent?

Often, it is not.

If the shedding is telogen effluvium, the hair follicles are not permanently destroyed.

Hair growth can resume once the trigger settles.

But recovery takes time. Hair grows slowly, so visible improvement may take several months.

Other causes can also occur at the same time. These include androgenetic alopecia, nutritional deficiencies, thyroid problems, and alopecia areata.

Persistent shedding should therefore not automatically be blamed on a GLP-1 drug.

How Can You Protect Your Hair During GLP-1 Weight Loss?

Maintain adequate nutrition

Do not let appetite suppression turn into severe under-eating.

Make protein-rich foods part of your meals. A balanced diet also provides the vitamins and minerals needed for normal hair growth.

Avoid unnecessarily rapid weight loss

Faster is not always better.

The American Academy of Dermatology recommends that people prone to hair loss lose weight slowly while taking GLP-1 drugs. [4]

Your healthcare professional can help set an appropriate weight-loss plan.

Do not rely on random supplements

Hair supplements are not a guaranteed solution.

If significant shedding develops, a healthcare professional can assess whether a nutrient deficiency or another condition is involved.

Handle your hair gently

Avoid tight hairstyles, excessive heat, and harsh chemical treatments during periods of heavy shedding.

These steps will not stop telogen effluvium. They can reduce additional hair damage.

Common Myths About GLP-1 Hair Loss

Myth: GLP-1 drugs permanently cause baldness.

Fact: Current evidence does not support that claim. Temporary shedding is a common explanation for hair loss after major weight loss.

Myth: Hair loss proves that GLP-1 drugs damage hair follicles.

Fact: The exact mechanism remains uncertain. Rapid weight loss and reduced nutrient intake may contribute significantly.

Myth: Biotin will prevent GLP-1 hair loss.

Fact: There is no strong evidence that high-dose biotin prevents this type of shedding in people without a deficiency.

Myth: Everyone taking semaglutide will lose hair.

Fact: Hair loss is reported in a minority of users. Individual risk varies.

Who Should Pay Attention?

Talk with a healthcare professional if you develop sudden or severe shedding.

You should also seek evaluation for bald patches, scalp inflammation, eyebrow loss, or progressive thinning.

A dermatologist can determine whether the problem is telogen effluvium, pattern hair loss, alopecia areata, or another condition.

Do not stop a prescribed GLP-1 medication without speaking with your healthcare professional.

What the Science Says

Bottom Line

GLP-1 drugs can be associated with hair loss.

But the medication may not be the only reason.

Rapid weight loss is a likely trigger in many cases. Reduced food intake may also affect protein and nutrient intake.

For many people, the resulting shedding may be telogen effluvium. This type of hair loss can improve as the body adjusts.

If shedding is severe, patchy, or persistent, get it evaluated.

GLP-1-related hair shedding can be real without being permanent.

References

1. Cheng PL, Chang HC. Glucagon-like peptide-1 receptor agonists and hair loss: A systematic review and meta-analysis. Diabetes Research and Clinical Practice. 2026;237:113333. doi:10.1016/j.diabres.2026.113333. PMID: 42155605.
2. Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling. Scientific Progress. 2026;109(2). doi:10.1177/00368504261444578. PMID: 41998799.
3. U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. 2026.
4. American Academy of Dermatology. How can GLP-1 drugs affect my skin, hair, and nails? Updated February 17, 2026.
5. Piraccini BM, Vañó-Galván S, Blume-Peytavi U, et al. Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes. Dermatology and Therapy. 2026;16(7):3345-3360. doi:10.1007/s13555-026-01792-0. PMID: 42249225.

Evidence Strength Summary: Moderate evidence supports an association between GLP-1 therapy and hair loss. The exact mechanism remains uncertain. Rapid weight loss and reduced nutritional intake are important suspected contributors.